Could Positive Results on a COVID Anitbody Drug Be Just What the Markets Need?

Markets were under pressure Tuesday on renewed fears about the spread of the coronavirus, but could late-breaking news out of a Regeneron trial turn things around?

Plus, after-hours earning action in shares of Micron, and will it be a happy holiday season for retailers?